DZ1926A1 - Pharmaceutical formulations. - Google Patents

Pharmaceutical formulations.

Info

Publication number
DZ1926A1
DZ1926A1 DZ950107A DZ950107A DZ1926A1 DZ 1926 A1 DZ1926 A1 DZ 1926A1 DZ 950107 A DZ950107 A DZ 950107A DZ 950107 A DZ950107 A DZ 950107A DZ 1926 A1 DZ1926 A1 DZ 1926A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
DZ950107A
Other languages
French (fr)
Original Assignee
Smithkline Beckman P L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beckman P L C filed Critical Smithkline Beckman P L C
Application granted granted Critical
Publication of DZ1926A1 publication Critical patent/DZ1926A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ950107A 1994-09-03 1995-08-02 Pharmaceutical formulations. DZ1926A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
DZ1926A1 true DZ1926A1 (en) 2002-02-17

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ950107A DZ1926A1 (en) 1994-09-03 1995-08-02 Pharmaceutical formulations.

Country Status (8)

Country Link
EP (1) EP0782443A1 (en)
JP (1) JPH10505595A (en)
AU (1) AU3471995A (en)
DZ (1) DZ1926A1 (en)
IL (1) IL115125A0 (en)
MA (1) MA23663A1 (en)
TR (1) TR199501082A2 (en)
WO (1) WO1996007408A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123563A (en) 1995-09-07 2002-02-10 Smithkline Beecham Corp Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive
IL131201A (en) * 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
ES2247817T3 (en) * 1998-07-06 2006-03-01 Nanobac Oy METHOD FOR THE ERADICATION OF NANOBACTERIES.
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
EP2575782A2 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Effervescent formulations comprising cephalosporin and clavulanic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2861607D1 (en) * 1977-11-26 1982-03-11 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE69425131T2 (en) * 1993-01-22 2001-03-15 Smithkline Beecham Plc USE OF CLAVULIC ACID AND AN ANTIBIOTIC FOR TREATING INFECTIONS

Also Published As

Publication number Publication date
EP0782443A1 (en) 1997-07-09
WO1996007408A1 (en) 1996-03-14
IL115125A0 (en) 1995-12-31
AU3471995A (en) 1996-03-27
MA23663A1 (en) 1996-04-01
TR199501082A2 (en) 1996-06-21
JPH10505595A (en) 1998-06-02

Similar Documents

Publication Publication Date Title
BR9610153A (en) Pharmaceutical formulations
BR9611626A (en) Pharmaceutical formulations
FR2705566B1 (en) New pharmaceutical compositions.
TR199901077A3 (en) Pharmaceutical formulations.
BR9607851B1 (en) combination and pharmaceutical formulation.
DE69530325D1 (en) AEROSOL DRUG FORMULATIONS
FI971279A (en) Drug
DE69525148D1 (en) PHARMACEUTICAL FORMULATION
NO954486D0 (en) Pharmaceutical formulation basis
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
NO981008D0 (en) Pharmaceutical formulation
DZ1559A1 (en) Pharmaceutical compositions.
DZ1926A1 (en) Pharmaceutical formulations.
ID16781A (en) PHARMACEUTICAL FORMULATIONS
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
BR9507768A (en) Pharmaceutical composition
MX9200532A (en) PHARMACEUTICAL AGENT.
FI973230A (en) New pharmaceutical formulation
MA26604A1 (en) PHARMACEUTICAL COMPOSITIONS.
FI951155A0 (en) Pharmaceutical preparation
FI923371A (en) EN PHARMACEUTICAL FORMULATION.
TR199601018A1 (en) Pharmaceutical compounds.
DZ2159A1 (en) Pharmaceutical products.
SE9404467D0 (en) Drug formulations
TR199500776A2 (en) Pharmaceutical compositions.